118 related articles for article (PubMed ID: 1661195)
1. Fibronectin, cholesterol and triglycerides ascitic fluid concentration in the prediction of malignancy.
Colloredo Mels G; Bellati G; Auriemma L; Perani C; Leandro G; Vacca N; Pinna N; Alfieri G; Ideo G
Ital J Gastroenterol; 1991 May; 23(4):179-86. PubMed ID: 1661195
[TBL] [Abstract][Full Text] [Related]
2. [Biochemical markers of the tumor origin of ascites].
Romette J; di Costanzo-Dufetel J
Pathol Biol (Paris); 1989 Jun; 37(6):720-4. PubMed ID: 2780109
[TBL] [Abstract][Full Text] [Related]
3. [Fibronectin in the ascitic fluid: its diagnostic significance].
Mal F; Nizard G; Labadie H; Trinchet JC; Garnier M; Beaugrand M
Gastroenterol Clin Biol; 1987 Oct; 11(10):639-42. PubMed ID: 2826281
[TBL] [Abstract][Full Text] [Related]
4. Ascitic fluid cholesterol in malignant and tubercular ascites.
Sood A; Garg R; Kumar R; Chhina RS; Arora S; Gupta R; Bhatia KL
J Assoc Physicians India; 1995 Nov; 43(11):745-7. PubMed ID: 8773030
[TBL] [Abstract][Full Text] [Related]
5. [Concentration of lipids in ascitic fluid and the concentration gradient of albumin in blood and ascites: diagnostic significance].
Barbare JC; Diab G; Delavenne J; Philippe JM; Vorhauer W; Latrive JP; Capron JP
Ann Gastroenterol Hepatol (Paris); 1989 Nov; 25(6):251-6. PubMed ID: 2619252
[TBL] [Abstract][Full Text] [Related]
6. Value of ascitic fibronectin and cholesterol concentration in the differentiation between malignancy-related and non-malignant ascites.
Archimandritis A; Kapsalas D; Douvara M; Tjivras M; Tsirantonaki M; Fertakis A
Ann Med Interne (Paris); 1996; 147(3):145-50. PubMed ID: 8796090
[TBL] [Abstract][Full Text] [Related]
7. Utility of ascitic fluid analysis in patients with malignancy-related ascites.
Salerno F; Restelli B; Incerti P; Annoni G; Capozza L; Badalamenti S; Lampertico P; Mojana E; Moser P; Tommasini M
Scand J Gastroenterol; 1990 Mar; 25(3):251-6. PubMed ID: 1690913
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of ascitic fluid cholesterol as a marker for malignant ascites.
Rana SV; Babu SG; Kocchar R
Med Sci Monit; 2005 Mar; 11(3):CR136-42. PubMed ID: 15735567
[TBL] [Abstract][Full Text] [Related]
9. [Value of ascitic lipids and sero-ascitic gradient of albumin in the differential diagnosis of ascites].
Cabral JE; Leitão MC; Guerra C; Tomé L; Pinto ML; Costa D; Monteiro G
Acta Med Port; 1989; 2(1):17-20. PubMed ID: 2773676
[TBL] [Abstract][Full Text] [Related]
10. [Genesis of fibronectin in ascites--detection of cellular and plasma fibronectin in portal and malignant ascites].
Rieder H; Ramadori G; Meyer zum Büschenfelde KH
Z Gastroenterol; 1991 Jan; 29(1):16-21. PubMed ID: 2058224
[TBL] [Abstract][Full Text] [Related]
11. Ascitic fluid cholesterol in differential diagnosis of ascites.
Garg R; Sood A; Arora S; Bhatia KL; Chawla AS; Gupta R; Chawla LS
J Assoc Physicians India; 1993 Oct; 41(10):644-6. PubMed ID: 8294324
[TBL] [Abstract][Full Text] [Related]
12. Role of fibronectin in diagnosis of malignant ascites.
Sood A; Moudgil A; Sood N; Kharay AS; Kaushal S; Narang AP
J Assoc Physicians India; 1997 Apr; 45(4):283-5. PubMed ID: 12521085
[TBL] [Abstract][Full Text] [Related]
13. [Chylous ascites in cirrhotic and non-cirrhotic patients].
Casafont F; López-Arias MJ; Crespo J; Dueñas C; Sánchez-Antolín G; Rivero M; Pons Romero F
Gastroenterol Hepatol; 1997; 20(6):291-4. PubMed ID: 9296843
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of malignant ascites. Comparison of ascitic fibronectin, cholesterol, and serum-ascites albumin difference.
Prieto M; Gómez-Lechón MJ; Hoyos M; Castell JV; Carrasco D; Berenguer J
Dig Dis Sci; 1988 Jul; 33(7):833-8. PubMed ID: 2837370
[TBL] [Abstract][Full Text] [Related]
15. Measurement of fibronectin concentration in benign and malignant ascites.
Adamsen S; Jönsson P; Brodin B; Lindberg B; Jorpes P
Eur J Surg; 1991 May; 157(5):325-8. PubMed ID: 1678645
[TBL] [Abstract][Full Text] [Related]
16. [Differentiation of malignant and non-malignant origin of ascites by determination of levels of cholesterol and lactate dehydrogenase in ascitic fluid is not absolute].
Gasko R; Klímová N
Vnitr Lek; 2000 Jan; 46(1):5-11. PubMed ID: 10953656
[TBL] [Abstract][Full Text] [Related]
17. Diagnosing ascitic etiology on a biochemical basis.
Bansal S; Kaur K; Bansal AK
Hepatogastroenterology; 1998; 45(23):1673-7. PubMed ID: 9840127
[TBL] [Abstract][Full Text] [Related]
18. [Immunological parameters in the differential diagnosis of ascites secondary to peritoneal carcinomatosis, hepatic cirrhosis, and congestive heart failure].
Roldan-Molina F; de Oliveira e Silva A; dos Santos TE; Genzini T; de Miranda MP; de Oliveira RM; Santo GC; D'Albuquerque LA
Arq Gastroenterol; 1992; 29(2):56-61. PubMed ID: 1284885
[TBL] [Abstract][Full Text] [Related]
19. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
